COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America COVID-19 in MS and NMOSD patients in LATAM

被引：33

作者：

Alonso, Ricardo ^{[1
,2
]}

Silva, Berenice ^{[2
]}

Garcea, Orlando ^{[2
]}

Correa Diaz, Patricio E. ^{[3
]}

dos Passos, Giordani Rodrigues ^{[4
]}

Ramirez Navarro, Deyanira A. ^{[5
]}

Garcia Valle, Luis A. ^{[6
]}

Rodriguez Salinas, Luis C. ^{[7
]}

Negrotto, Laura ^{[8
]}

Luetic, Geraldine ^{[9
]}

Tkachuk, Veronica A. ^{[10
]}

Miguez, Jimena ^{[11
]}

Diaz de Bedoya, Fernando Hamuy ^{[12
,13
]}

Goiry, Lorna Galleguillos ^{[14
]}

Ramirez Sanchez, Nicia E. ^{[15
]}

Burgos, Marcos ^{[16
]}

Steinberg, Judith ^{[17
]}

Balbuena, Maria E. ^{[10
]}

Monterrey Alvarez, Priscilla ^{[18
]}

Lopez, Pablo A. ^{[19
]}

Ysrraelit, Maria C. ^{[8
]}

Leon, Rosalba A.

Cohen, Aron Benzadon ^{[20
]}

Gracia, Fernando ^{[21
]}

Molina, Omaira ^{[22
]}

Casas, Magdalena ^{[23
]}

Deri, Norma H. ^{[24
]}

Pappolla, Agustin ^{[11
]}

Patrucco, Liliana ^{[11
]}

Cristiano, Edgardo ^{[25
]}

Tavolini, Dario ^{[26
]}

Nadur, Debora ^{[27
]}

Granda, Ana M. Toral ^{[28
]}

Weiser, Roberto ^{[29
]}

Cassara, Fatima Pagani ^{[30
,31
]}

Sinay, Vladimiro ^{[31
]}

Carcamo Rodriguez, Claudia ^{[32
]}

Lazaro, Luciana G. ^{[2
]}

Menichini, Maria L. ^{[33
]}

Piedrabuena, Raul ^{[34
,35
]}

Orozco Escobar, Geraldine ^{[36
]}

Carra, Adriana ^{[17
]}

Chertcoff, Anibal ^{[17
]}

Santos Pujols, Biany ^{[37
]}

Vrech, Carlos ^{[38
]}

Tarulla, Adriana ^{[39
]}

Carvajal, Rene ^{[40
]}

Mainella, Carolina ^{[41
]}

Becker, Jefferson ^{[4
]}

Peeters, Liesbet M. ^{[42
,43
,44
]}

机构：

[1] Hosp Ramos Mejia, Ctr Univ Esclerosis Multiple, Buenos Aires, DF, Argentina

[2] Hosp Univ Sanatorio Guemes, Serv Neurol, Caba, Argentina

[3] Hosp Carlos Andrade Main, Quito, Ecuador

[4] Pontificia Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Porto Alegre, RS, Brazil

[5] Hosp Docente Padre Billini, Santo Domingo, Dominican Rep

[6] Hosp Mil Escuela Managua, Managua, Nicaragua

[7] Inst Hondureno Seguridad Social, Comayagua, Honduras

[8] FLENI, Buenos Aires, DF, Argentina

[9] Inst Neurociencias Rosario, Rosario, Argentina

[10] Hosp Clin Jose San Martin, Buenos Aires, DF, Argentina

[11] Hosp Italian Buenos Aires, Buenos Aires, DF, Argentina

[12] Hosp IMT, Dept Neurol, Asuncion, Paraguay

[13] Dept Neurol Diagnost Codas Thompson, Asuncion, Paraguay

[14] Clin Alemana Santiago, Santiago, Chile

[15] Hosp Dr Mario C Rivas San Pedro Sula, San Pedro Sula, Honduras

[16] Hosp San Bernardo, Salta, Argentina

[17] Hosp Britan Buenos Aires, Buenos Aires, DF, Argentina

[18] Hosp San Rafael, Alajuela, Costa Rica

[19] Hosp Aleman Buenos Aires, Buenos Aires, DF, Argentina

[20] MD Complejo Hosp CSS, Panama City, Panama

[21] Hosp Santo Tomas, Panama City, Panama

[22] Policlin Maracaibo, Maracaibo, Venezuela

[23] Hosp JM Ramos Mejia, Buenos Aires, DF, Argentina

[24] Diabaid, Buenos Aires, DF, Argentina

[25] Ctr Esclerosis Multiple Buenos Aires, Buenos Aires, DF, Argentina

[26] INECO Neurociencias Orono, Rosario, Argentina

[27] Hosp Clin Buenos Aires, Hosp Naval, Buenos Aires, DF, Argentina

[28] Hosp Jose Carrasco Arteaga, Cuenca, Ecuador

[29] Hosp Horacio Oduber, Caya Punta Brabo, Aruba

[30] Hosp Univ Austral, Buenos Aires, DF, Argentina

[31] Fdn Favaloro, Buenos Aires, DF, Argentina

[32] Univ Catolica Chile, Santiago, Chile

[33] Sanatorio Britan Rosario, Rosario, Argentina

[34] Clin Reina Fabiola, Cordoba, Argentina

[35] Inst Lennox, Cordoba, Argentina

[36] Hosp Patrocinio P Ruiz, San Cristobal, Venezuela

[37] Hosp Reg Univ Jose Ma Cabral & Baez, Cordoba, Argentina

[38] Sanatorio Allende, Cordoba, Argentina

[39] Hosp Agudos P Pinero, Buenos Aires, DF, Argentina

[40] Hosp Univ Nacl Colombia, Bogota, Colombia

[41] Hosp Espanol Rosario, Rosario, Argentina

[42] Hasselt Univ, Univ Multiple Sclerosis Ctr, Hasselt, Belgium

[43] Hasselt Univ, Biomed Res Inst, Hasselt, Belgium

[44] Hasselt Univ, Data Sci Inst, Hasselt, Belgium

[45] MS Int Federat, London, England

[46] Infect Dis Unit Sanatorio Guemes, Buenos Aires, DF, Argentina

[47] Hosp Univ CEMIC, Serv Neurol, Buenos Aires, DF, Argentina

来源：

MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2021年 / 51卷

关键词：

multiple sclerosis; NMOSD; COVID-19; registries; Latin America;

D O I：

10.1016/j.msard.2021.102886

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Background: There is no data regarding COVID-19 in Multiple Sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) patients in Latin America. Objective: The objective of this study was to describe the clinical characteristics and outcomes of patients included in RELACOEM, a LATAM registry of MS and NMOSD patients infected with COVID-19. Methods: RELACOEM is a longitudinal, strictly observational registry of MS and NMOSD patients who suffer COVID-19 and Dengue in LATAM. Inclusion criteria to the registry were either: (1) a biologically confirmed COVID-19 diagnosis based on a positive result of a COVID-19 polymerase chain reaction (PCR) test on a naso-pharyngeal swab; or (2) COVID-19-typical symptoms (triad of cough, fever, and asthenia) in an epidemic zone of COVID-19. Descriptive statistics were performed on demographic and clinical variables. The cohort was later stratified for MS and NMOSD and univariate and multivariate logistic regression analysis was performed to identify variables associated with hospitalizations/intensive critical units (ICU) admission. Results: 145 patients were included in the registry from 15 countries and 51 treating physicians. A total of 129 (89%) were MS patients and 16 (11%) NMOSD. 81.4% patients had confirmed COVID-19 and 18.6% were suspected cases. 23 (15.8%) patients were hospitalized, 9 (6.2%) required ICU and 5 (3.4 %) died due to COVID-19. In MS patients, greater age (OR 1.17, 95% CI 1.05 - 1.25) and disease duration (OR 1.39, 95%CI 1.14-1.69) were associated with hospitalization/ICU. In NMOSD patients, a greater age (54.3 vs. 36 years, p=<0.001), increased EDSS (5.5 vs 2.9, p=0.0012) and disease duration (18.5 vs. 10.3 years, p=0.001) were significantly associated with hospitalization/ICU. Conclusion: we found that in MS patients, age and disease duration was associated with hospitalization and ICU admission requirement, while age, disease duration and EDSS was associated in NMOSD.

引用

页数：7

共 50 条

[1] Impact of COVID-19 and vaccination on multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD)
Apiwattanakul, Metha
Ounmuang, Chawarat
Aungsumart, Saharat
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2025, 95
[2] COVID-19 in patients with multiple sclerosis and neuromyelitis optica spectrum disorder in Colombia
Zuluaga Rodas, M.
Orozco-Gonzalez, C.
Ortiz-Salas, P.
Vagner, B.
Gortari, J.
Camacho-Barbosa, J.
Donado-Gomez, J.
Duque-Zapata, N.
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 235 - 236
[3] Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review
Mirmosayyeb, O.
Ghaffary, E. M.
Vaheb, S.
Pourkazemi, R.
Shaygannejad, V.
REVUE NEUROLOGIQUE, 2023, 179 (04) : 265 - 281
[4] COVID-19 among patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD): a systematic review of current evidence
Barzegar, M.
Mirmosayyeb, O.
Afshari-Safavi, A.
Shaygannejad, V.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 115 - 116
[5] COVID-19 in neuromyelitis optica spectrum disorder patients in Poland
Podlecka-Pietowska, A.
Barc, K.
Filipiak, A.
Nojszewska, M.
Zakrzewska-Pniewska, B.
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 158 - 158
[6] COVID-19 in neuromyelitis optica spectrum disorder patients in Poland
Podlecka-Pietowska, Aleksandra
Barc, Krzysztof
Denisiuk, Agata
Nojszewska, Monika
Zakrzewska-Pniewska, Beata
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 60
[7] COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder - The Czech experience
Menkyova, I.
Drahota, J.
Adamkova, J.
Ampapa, R.
Grunermelova, M.
Peterka, M.
Recmanova, E.
Rokova, P.
Rous, M.
Stetkarova, I.
Valis, M.
Vachova, M.
Woznicova, I.
Horakova, D.
Stastna, D.
EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 826 - 827
[8] Prevalence of COVID-19 Infection in Patients with Neuromyelitis Optica Spectrum Disorder
Moghadasi, Abdorreza Naser
Mohammadi, Aida
Sahraian, Mohammad Ali
Ghajarzadeh, Mahsa
ARCHIVES OF NEUROSCIENCE, 2021, 8 (04)
[9] Evaluation of COVID-19 infection in patients with Neuromyelitis optica spectrum disorder (NMOSD): A report from Iran
Sahraian, Mohammad Ali
Azimi, Amirreza
Navardi, Samira
Rezaeimanesh, Nasim
Moghadasi, Abdorreza Naser
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 44
[10] Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia
Stastna, Dominika
Menkyova, Ingrid
Drahota, Jiri
Mazouchova, Aneta
Adamkova, Jana
Ampapa, Radek
Grunermelova, Marketa
Peterka, Marek
Recmanova, Eva
Rockova, Petra
Rous, Matous
Stetkarova, Ivana
Valis, Martin
Vachova, Marta
Woznicova, Ivana
Horakova, Dana
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 54

← 1 2 3 4 5 →